scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Ambalangodage C Jayasuriya | |
Brian Snoddy | |||
P2860 | cites work | A gentamicin-releasing coating for cementless hip prostheses-Longitudinal evaluation of efficacy using in vitro bio-optical imaging and its wide-spectrum antibacterial efficacy | Q84459631 |
Characterization and antibacterial activity of amoxicillin-loaded electrospun nano-hydroxyapatite/poly(lactic-co-glycolic acid) composite nanofibers | Q85494551 | ||
Eradicating antibiotic-resistant biofilms with silver-conjugated superparamagnetic iron oxide nanoparticles | Q85542731 | ||
Diagnosis and management of osteomyelitis | Q27009101 | ||
Functionalized carbon nanotubes for potential medicinal applications | Q28392143 | ||
The future of biologic coatings for orthopaedic implants | Q28394906 | ||
Injectable biodegradable temperature-responsive PLGA-PEG-PLGA copolymers: synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogels | Q30986623 | ||
The use of superparamagnetic nanoparticles for prosthetic biofilm prevention | Q33405610 | ||
Sharper and faster "nano darts" kill more bacteria: a study of antibacterial activity of individually dispersed pristine single-walled carbon nanotube | Q33515332 | ||
In vitro analysis of nanoparticulate hydroxyapatite/chitosan composites as potential drug delivery platforms for the sustained release of antibiotics in the treatment of osteomyelitis | Q33709398 | ||
Clinical practice. Infection associated with prosthetic joints | Q33771840 | ||
Engineered nanomedicine for myeloma and bone microenvironment targeting. | Q33926003 | ||
Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often? | Q33978014 | ||
The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. | Q34052763 | ||
Bioactive coatings for orthopaedic implants-recent trends in development of implant coatings. | Q34072309 | ||
Novel antibacterial nanofibrous PLLA scaffolds. | Q34107698 | ||
Cytotoxicity of monodispersed chitosan nanoparticles against the Caco-2 cells. | Q34275320 | ||
The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant | Q34981148 | ||
Bioactive silica-based nanoparticles stimulate bone-forming osteoblasts, suppress bone-resorbing osteoclasts, and enhance bone mineral density in vivo | Q35795104 | ||
Prophylactic use of antibiotic bone cement: an emerging standard--in the affirmative | Q35801027 | ||
Prophylactic use of antibiotic bone cement: an emerging standard--in opposition | Q35801030 | ||
Bioactive glasses for in situ tissue regeneration | Q35814269 | ||
Biomimetic three-dimensional nanocrystalline hydroxyapatite and magnetically synthesized single-walled carbon nanotube chitosan nanocomposite for bone regeneration | Q35972691 | ||
Silica-based mesoporous organic-inorganic hybrid materials | Q36469015 | ||
Carbon nanotube applications for tissue engineering | Q36578293 | ||
Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement | Q36641806 | ||
Calcium phosphate nanoparticles: a future therapeutic platform for the treatment of osteomyelitis? | Q37147653 | ||
Treatment of long bone osteomyelitis with a mechanically stable intramedullar antibiotic dispenser: nineteen consecutive cases with a minimum of 12 months follow-up | Q37349006 | ||
Translation of a solution-based biomineralization concept into a carrier-based delivery system via the use of expanded-pore mesoporous silica | Q37476196 | ||
Continuous nanostructures for the controlled release of drugs | Q37482030 | ||
Prosthetic joint infection risk after TKA in the Medicare population | Q37483283 | ||
Recent progress in inorganic and composite coatings with bactericidal capability for orthopaedic applications. | Q37807132 | ||
Chitosan-based drug delivery systems | Q38007844 | ||
Incidence, characteristics, and outcomes of patients with bone and joint infections due to community-associated methicillin-resistant Staphylococcus aureus: a systematic review | Q38075466 | ||
Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees | Q38103425 | ||
Antibiotic cement-coated rods: an effective treatment for infected long bones and prosthetic joint nonunions | Q38256025 | ||
Silver nanoparticles and their orthopaedic applications | Q38448337 | ||
Copper-doped mesoporous silica nanospheres, a promising immunomodulatory agent for inducing osteogenesis. | Q38817556 | ||
Mechanical, material, and antimicrobial properties of acrylic bone cement impregnated with silver nanoparticles. | Q38920910 | ||
A novel modified acrylic bone cement matrix. A step forward on antibiotic delivery against multiresistant bacteria responsible for prosthetic joint infections | Q39013151 | ||
The influence of polymeric component of bioactive glass-based nanocomposite paste on its rheological behaviors and in vitro responses: hyaluronic acid versus sodium alginate | Q39079319 | ||
Nanoparticulate zinc oxide as a coating material for orthopedic and dental implants. | Q39186419 | ||
Infection burden for hip and knee arthroplasty in the United States | Q39848742 | ||
Deposition of silver nanoparticles on titanium surface for antibacterial effect | Q40380921 | ||
Local antibiotic therapy in osteomyelitis | Q41034784 | ||
Antibiotic cement-coated plates for management of infected fractures | Q41498947 | ||
A biodegradable gentamicin-hydroxyapatite-coating for infection prophylaxis in cementless hip prostheses | Q41568960 | ||
Injectable scaffolds for bone regeneration | Q41710738 | ||
Protein-mediated assembly of nanodiamond hydrogels into a biocompatible and biofunctional multilayer nanofilm | Q42449134 | ||
Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening. | Q42603653 | ||
Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles | Q42807243 | ||
Liposome combined porous beta-TCP scaffold: preparation, characterization, and anti-biofilm activity | Q43080159 | ||
Treatment of osteomyelitis with teicoplanin-encapsulated biodegradable thermosensitive hydrogel nanoparticles. | Q43104462 | ||
A novel nano drug delivery system based on tigecycline-loaded calciumphosphate coated with poly-DL-lactide-co-glycolide. | Q43285981 | ||
Influence of lactose addition to gentamicin-loaded acrylic bone cement on the kinetics of release of the antibiotic and the cement properties. | Q43286897 | ||
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment | Q43741105 | ||
Antibiotic bone cement and the incidence of deep infection after total knee arthroplasty | Q44098105 | ||
Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy | Q44140404 | ||
Prophylaxis of infection and effects on osseointegration using a tobramycin-periapatite coating on titanium implants--an experimental study in the rabbit. | Q44206367 | ||
Nanoparticulate silver. A new antimicrobial substance for bone cement | Q44969383 | ||
A controlled release of antibiotics from calcium phosphate-coated poly(lactic-co-glycolic acid) particles and their in vitro efficacy against Staphylococcus aureus biofilm | Q45173405 | ||
Development of bioactive and biodegradable chitosan-based injectable systems containing bioactive glass nanoparticles | Q45354488 | ||
A thermosensitive chitosan/poly(vinyl alcohol) hydrogel containing hydroxyapatite for protein delivery | Q46189994 | ||
Obesity and perioperative morbidity in total hip and total knee arthroplasty patients | Q46197015 | ||
Bactericidal effect of silver-reinforced carbon nanotube and hydroxyapatite composites. | Q46568680 | ||
Synthesis of nitric oxide-releasing gold nanoparticles | Q46572021 | ||
An innovative, easily fabricated, silver nanoparticle-based titanium implant coating: development and analytical characterization. | Q46792259 | ||
Injectability, microstructure and release properties of sodium fusidate-loaded apatitic cement as a local drug-delivery system | Q46841515 | ||
The treatment of intramedullary osteomyelitis of the femur and tibia using the Reamer-Irrigator-Aspirator system and antibiotic cement rods | Q46884954 | ||
Size effect of calcium phosphate coated with poly-DL-lactide- co-glycolide on healing processes in bone reconstruction. | Q47429538 | ||
Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection | Q47959702 | ||
Maintenance of hardware after early postoperative infection following fracture internal fixation. | Q50699908 | ||
Thermo-responsive chitosan-graft-poly(N-isopropylacrylamide) injectable hydrogel for cultivation of chondrocytes and meniscus cells. | Q51100401 | ||
Characterization of clinical strains of MSSA, MRSA and MRSE isolated from skin and soft tissue infections and the antibacterial activity of ZnO nanoparticles. | Q51171774 | ||
Physical characterization and osteogenic activity of the quaternized chitosan-loaded PMMA bone cement. | Q54319650 | ||
The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli. | Q54345955 | ||
A biodegradable antibiotic-impregnated scaffold to prevent osteomyelitis in a contaminated in vivo bone defect model | Q61867700 | ||
Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics | Q73953579 | ||
The use of an antibiotic-impregnated, osteoconductive, bioabsorbable bone substitute in the treatment of infected long bone defects: early results of a prospective trial | Q78341721 | ||
Micro- and nano-injectable composite biomaterials containing calcium phosphate coated with poly(DL-lactide-co-glycolide) | Q80391067 | ||
Biodegradable drug delivery system for the treatment of bone infection and repair | Q80527518 | ||
Risk factors for infection after knee arthroplasty. A register-based analysis of 43,149 cases | Q83144078 | ||
Biocompatibility of electrospun halloysite nanotube-doped poly(lactic-co-glycolic acid) composite nanofibers | Q83229666 | ||
A comparative study of the thermal and dynamic mechanical behaviour of quenched and annealed bioresorbable poly-L-lactide/α-tricalcium phosphate nanocomposites | Q83398611 | ||
Injectable and thermosensitive PLGA-g-PEG hydrogels containing hydroxyapatite: preparation, characterization and in vitro release behavior | Q83762153 | ||
Antibacterial efficacy of a new gentamicin-coating for cementless prostheses compared to gentamicin-loaded bone cement | Q83859517 | ||
P921 | main subject | nanomaterial | Q967847 |
P304 | page(s) | 822-833 | |
P577 | publication date | 2016-04-30 | |
P1433 | published in | Materials Science and Engineering C-Biomimetic and Supramolecular Systems | Q15763790 |
P1476 | title | The use of nanomaterials to treat bone infections | |
P478 | volume | 67 |
Q58695509 | Biomimetic delivery of signals for bone tissue engineering |
Q38914125 | Gentamicin-Loaded Thermosetting Hydrogel and Moldable Composite Scaffold: Formulation Study and Biologic Evaluation |
Q64985958 | Gentamicin-loaded silk/nanosilver composite scaffolds for MRSA-induced chronic osteomyelitis. |
Q51011571 | Nanoparticles: a promising new therapeutic platform for bone regeneration? |
Q48630590 | The immobilization of antibiotic-loaded polymeric coatings on osteoarticular Ti implants for the prevention of bone infections. |
Search more.